336
Views
24
CrossRef citations to date
0
Altmetric
Research Report

Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30

, , , , , , , & show all
Pages 831-837 | Published online: 09 Jan 2014

References

  • Chen E, Nguyen J, Zhang L et al. Quality of life in patients with brain metastases using the EORTC QLQ-BN20 and QLQ-C30. J. Radiat. Oncol. 1, 179–186 (2012).
  • Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl Cancer Inst. 85(5), 365–376 (1993).
  • Osoba D, Aaronson NK, Muller M et al. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual. Life Res. 5(1), 139–150 (1996).
  • Leung A, Lien K, Zeng L et al. The EORTC QLQ-BN20 for assessment of quality of life in patients receiving treatment or prophylaxis for brain metastases: a literature review. Expert Rev. Pharmacoecon. Outcomes Res. 11(6), 693–700 (2011).
  • Klein M, Taphoorn MJ, Heimans JJ et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J. Clin. Oncol. 19(20), 4037–4047 (2001).
  • Taphoorn MJ, Claassens L, Aaronson NK et al.; EORTC Quality of Life Group, and Brain Cancer, NCIC and Radiotherapy Groups. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients. Eur. J. Cancer 46(6), 1033–1040 (2010).
  • Blonski M, Taillandier L, Herbet G et al. Combination of neoadjuvant chemotherapy followed by surgical resection as a new strategy for WHO grade II gliomas: a study of cognitive status and quality of life. J. Neurooncol. 106(2), 353–366 (2012).
  • Budrukkar A, Jalali R, Dutta D et al. Prospective assessment of quality of life in adult patients with primary brain tumors in routine neurooncology practice. J. Neurooncol. 95(3), 413–419 (2009).
  • Caissie A, Nguyen J, Chen E et al. Quality of life in patients with brain metastases using the EORTC QLQ-BN2D2 and QLQ-C15-PAL. Int. J. Radiat. Oncol. Biol. Phy. 1–8 (2011).
  • Erharter A, Giesinger J, Kemmler G et al. Implementation of computer-based quality-of-life monitoring in brain tumor outpatients in routine clinical practice. J. Pain Symptom Manage. 39(2), 219–229 (2010).
  • Flechl B, Ackerl M, Sax C et al. Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors. J. Neurooncol. 109(2), 331–339 (2012).
  • Giesinger J, Miriam G, Erharter A et al. Do neurooncological patients and their significant others agree on quality of life ratings? Health Qual. Life Outcomes 7, 87 (2009).
  • Grabenbauer GG, Gerber KD, Ganslandt O et al. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 75(1), 164–169 (2009).
  • Holzner G, Schauer-Maurer G, Stockhammer G et al. Patient reported outcome monitoring using a tablet PC is suitable for measuring quality of life in patients with gliomas]. Wien. Med. Wochenschr. 161(1–2), 6–12 (2011).
  • Keime-Guibert F, Chinot O, Taillandier L et al.; Association of French-Speaking Neuro-Oncologists. Radiotherapy for glioblastoma in the elderly. N. Engl. J. Med. 356(15), 1527–1535 (2007).
  • Khoshnevisan A, Yekaninejad MS, Ardakani SK, Pakpour AH, Mardani A, Aaronson NK. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran. Health Qual. Life Outcomes 10, 54 (2012).
  • Maringwa J, Quinten C, King M et al.; EORTC PROBE Project and Brain Cancer Group. Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Ann. Oncol. 22(9), 2107–2112 (2011).
  • Steinmann D, Schäfer C, van Oorschot B et al. Effects of radiotherapy for brain metastases on quality of life (QoL). Prospective pilot study of the DEGRO QoL working party. Strahlenther. Onkol. 185(3), 190–197 (2009).
  • Weber DC, Caparrotti F, Laouiti M, Malek K. Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life. Radiat. Oncol. 6, 79 (2011).
  • Yavas C, Dogan U, Yavas G, Araz M, Ata OY. Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study. Support. Care Cancer 20(10), 2343–2347 (2012).
  • Yavas C, Zorlu F, Ozyigit G et al. Prospective assessment of health-related quality of life in patients with low-grade glioma: a single-center experience. Support. Care Cancer 20(8), 1859–1868 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.